Article Correctness Is Author's Responsibility: Potential new heartburn drug studied at VUMC

(Vanderbilt University Medical Center) An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor (PPI), a new study suggests.